A recent agreement to update the Italian list of officinal (medically usable) plants has caused some unfounded consternation in the country’s CBD industry.
The Italian Agriculture Ministry and the ministries of Health and Ecological Transition, along with the State-Regions Conference, reached an agreement to include hemp seeds and their by-products on the list – but at the same time inserting cannabis flowers, leaves or “active substances” (cannabinoids) destined for medical purposes under the regulatory framework of Narcotics Law n.309/90.